Delayed Remission Following Sequential Infusion of Humanized CD19- and CD22-modified CAR-T Cells in a Patient with Relapsed/refractory Acute Lymphoblastic Leukemia and Prior Exposure to Murine-Derived CD19-directed CAR-T Cells.
OncoTargets and Therapy（2019）
关键词
chimeric antigen receptor,anti-CD19,anti-CD22,humanized,acute lymphoblastic leukemia,relapsed
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要